Pazopanib in metastatic osteosarcoma: significant clinical response in three consecutive patients

Acta Oncol. 2014 Oct;53(10):1451-4. doi: 10.3109/0284186X.2014.948062. Epub 2014 Aug 21.

Authors

Akmal Safwat¹, Anders Boysen, Arne Lücke, Philip Rossen

Affiliation

¹ Department of Oncology, Aarhus University Hospital , Aarhus , Denmark.

PMID: 25143189
DOI: 10.3109/0284186X.2014.948062

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Angiogenesis Inhibitors / administration & dosage*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Bone Neoplasms / drug therapy*
Bone Neoplasms / pathology
Female
Humans
Humerus
Indazoles
Lung Neoplasms / drug therapy*
Lung Neoplasms / secondary
Male
Neoplasms, Radiation-Induced / drug therapy*
Osteosarcoma / drug therapy*
Osteosarcoma / secondary
Pyrimidines / administration & dosage*
Skull Neoplasms / drug therapy*
Sulfonamides / administration & dosage*
Young Adult

Substances

Angiogenesis Inhibitors
Indazoles
Pyrimidines
Sulfonamides
pazopanib